Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Nevzorova, T. Pestrikova, E. Kochetkova, O. Golotina, O. Shekunova, P. Lukyanov (Vladivostok, Russian Federation; Srasbourg, France). Endothelin-1 level of functional tests and arterial deoxygenation in patients with COPD and cirrhosis. Eur Respir J 2009; 34: Suppl. 53, 3480

Member's Comments

No comment yet.

Related content which might interest you: Endothelin-1 level and central arterial stiffness in patients with COPD and hepatic cirrhosis Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Sitaxsentan for pulmonary arterial hypertension (PAH) patients with clinical deterioration or significantly abnormal liver function test on bosentan Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Platelet activity in patients with COPD and concomitant arterial hypertension Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Pulmonary arterial pressure response during exercise in COPD patients and healthy subjects Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Arterial stiffness and endothelial dysfunction in stable COPD patients Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Microvascular changes in COPD patients with severe pulmonary hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Comparison of arterial and venous blood gases analysis in patients with exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 326s Year: 2007 NT-proBNP variation in stable pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 770 Year: 2009 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Prognostic significance of pulmonary arterial pressure in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010